These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 25601211)
1. A case of rupioid psoriasis exacerbated by systemic glucocorticosteroids. Bonciani D; Bonciolini V; Antiga E; Verdelli A; Caproni M; Senetta R Int J Dermatol; 2015 Apr; 54(4):e100-2. PubMed ID: 25601211 [No Abstract] [Full Text] [Related]
2. Psoriasiform reactions during treatment with abatacept. Conde-Montero E; Baniandrés-Rodríguez O; Mendoza-Cembranos MD; Horcajada-Reales C; Suárez-Fernández R Indian J Dermatol Venereol Leprol; 2014; 80(1):92-3. PubMed ID: 24448144 [No Abstract] [Full Text] [Related]
3. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not? Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021 [No Abstract] [Full Text] [Related]
4. Diffuse psoriasis induced by docetaxel in a 62-year-old woman with breast carcinoma. Mapelli ET; Gualandri L; Menni S; Cerri A G Ital Dermatol Venereol; 2016 Jun; 151(3):309-10. PubMed ID: 27176084 [No Abstract] [Full Text] [Related]
5. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment. Brenner M; Molin S; Ruebsam K; Weisenseel P; Ruzicka T; Prinz JC Br J Dermatol; 2009 Oct; 161(4):964-6. PubMed ID: 19681858 [No Abstract] [Full Text] [Related]
6. Combined classic and iatrogenic Kaposi's sarcoma. Corticosteroid withdrawal can result in remission. Kroumpouzos G; Delaney T; Phillips TJ Postgrad Med; 2000 Aug; 108(2):103-6. PubMed ID: 10951749 [No Abstract] [Full Text] [Related]
7. Psoriasiform drug eruption due to abatacept. Kato K; Satoh T; Nishizawa A; Yokozeki H Acta Derm Venereol; 2011 May; 91(3):362-3. PubMed ID: 21336469 [No Abstract] [Full Text] [Related]
8. Drug eruption and exacerbation of psoriasis related to bupropion. Gómez-Fernández C; Herranz Pinto P; Casado Verrier B; Sendagorta Cudós E; Beato-Merino MJ; Jiménez MC Eur J Dermatol; 2011; 21(1):120-1. PubMed ID: 21233071 [No Abstract] [Full Text] [Related]
9. Psoriasiform Eruption Secondary to the Use of Adalimumab. Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828 [TBL] [Abstract][Full Text] [Related]
10. Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment. Goss JM; Nord KM; Olarte MR; Grossman ME Br J Dermatol; 2007 Mar; 156(3):582. PubMed ID: 17300257 [No Abstract] [Full Text] [Related]
18. [Severe psoriasis induced by chloroquine (nivaquine)]. Nicolas JF; Mauduit G; Haond J; Chouvet B; Thivolet J Ann Dermatol Venereol; 1988; 115(3):289-93. PubMed ID: 2970239 [TBL] [Abstract][Full Text] [Related]
19. Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology. Yamamoto M; Ikeda M; Kodama H; Sano S J Dermatol; 2008 Nov; 35(11):732-6. PubMed ID: 19120769 [TBL] [Abstract][Full Text] [Related]
20. Ocrelizumab-induced psoriasiform dermatitis in a patient with multiple sclerosis. Darwin E; Romanelli P; Lev-Tov H Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]